Both assays were used to assess the effects of GSK3368715 in Toledo tumor xenografts, and successfully demonstrated the dose-dependent decrease in levels of ADM-R225, but not total, hnRNP-A1 in tumor tissue. Here, HNRNPA1 is linked to neoplasm.